What is the recommended dosing of Augmentin (amoxicillin-clavulanate) for the treatment of sinusitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Augmentin (Amoxicillin-Clavulanate) Dosing for Sinusitis

For sinusitis treatment, high-dose amoxicillin-clavulanate (875/125 mg twice daily for 10-14 days) is recommended as the optimal dosing regimen, especially for patients who have not responded to initial amoxicillin therapy or in regions with high antibiotic resistance. 1

Initial Treatment Approach

  • Amoxicillin is typically the first-line antibiotic for uncomplicated sinusitis, with a recommended treatment duration of 10-14 days 1
  • For patients who fail to improve after 3-5 days of amoxicillin therapy, switching to high-dose amoxicillin-clavulanate is recommended 1

Specific Augmentin Dosing Recommendations

Standard Dosing

  • For adults with sinusitis:
    • 875/125 mg twice daily for 10-14 days 1, 2
    • Alternative: 500/125 mg three times daily for 10-14 days 1, 3

High-Dose Regimen

  • For patients with suspected resistant organisms or treatment failure:
    • 90 mg/kg amoxicillin and 6.4 mg/kg clavulanate (not to exceed 2 g every 12 hours) 1

Treatment Duration

  • Standard course: 10-14 days 1
  • Continue treatment until the patient is well for 7 days after symptom resolution 1
  • Some physicians continue treatment until the patient is improved symptomatically to near normal 1

Clinical Considerations

When to Use High-Dose Augmentin

  • Poor response to initial amoxicillin therapy 1
  • Regions with high incidence of antibiotic resistance 1
  • Suspected resistant pathogens 1

Advantages of Twice-Daily Dosing

  • The twice-daily 875/125 mg regimen has shown at least equivalent or superior pharmacokinetics and tissue penetration compared to the three-times-daily 500/125 mg regimen 4
  • Better patient compliance with fewer daily doses 2
  • Similar clinical success rates between twice-daily and three-times-daily dosing (93% vs 88%) 2

Monitoring Response

  • Evaluate improvement of signs and symptoms after 3-5 days of treatment 1
  • If symptoms are improving, continue treatment until the patient is well for 7 days 1
  • If minimal or no improvement after 3-5 days, consider switching to a different antibiotic 1

Common Pitfalls and Caveats

  • Diarrhea is the most common adverse event with amoxicillin-clavulanate therapy 1
  • The higher dose of amoxicillin in the 875/125 mg formulation helps overcome resistance while maintaining the same amount of clavulanic acid, potentially reducing gastrointestinal side effects 4
  • Ensure patients complete the full course of antibiotics to prevent relapse, even if symptoms improve before completion 1
  • For patients allergic to or intolerant of amoxicillin-clavulanate, alternatives include cephalosporins, macrolides, or quinolones 1

Treatment Response Assessment

  • Partial response: Patient is symptomatically improved but not back to normal at the end of the first course of antibiotics - continue treatment for another 10-14 days 1
  • Poor response: Little or no symptomatic improvement after the first course - switch to a broader-spectrum antibiotic 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Comparison of the effectiveness of levofloxacin and amoxicillin-clavulanate for the treatment of acute sinusitis in adults.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.